To study the tumor cell-intrinsic role of Nrp2 in the aggressive form of CRC, we aimed to generate a CRC model closely resembling the clinical correlate, EMT-high/stroma-rich CMS4 subtype. The gene discussed is NRP2; the disease is neoplasm.